tiprankstipranks
Codexis (CH:4QK)
:4QK
Switzerland Market
4QK
Codexis
RESEARCH TOOLSreports

Codexis (4QK) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

4QK Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Codexis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4QK Stock 12 Month Forecast

Average Price Target

CHF5.93
Based on 4 Wall Street analysts offering 12 month price targets for Codexis in the last 3 months. The average price target is CHF5.93 with a high forecast of CHF8.90 and a low forecast of CHF1.62. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF8.90Average Price TargetCHF5.93Lowest Price TargetCHF1.62
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CH:4QK
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/25/26
Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)
Cantor Fitzgerald Analyst forecast on CH:4QK
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
CHF8.9
Buy
―
Reiterated
06/16/26
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (NASDAQ: EWTX), Gilead Sciences (NASDAQ: GILD) and Codexis (NASDAQ: CDXS)
Piper Sandler Analyst forecast on CH:4QK
Allison Bratzel
Piper Sandler
Piper Sandler
CHF7.28
Buy
―
Reiterated
05/08/26
Codexis (CDXS) Gets a Buy from Piper Sandler
TD Cowen Analyst forecast on CH:4QK
Brendan Smith
TD Cowen
TD Cowen
CHF1.62
Hold
―
Reiterated
05/07/26
Codexis: Neutral Stance Maintained as Execution Risks Offset Solid Q1; $2 Price Target Reaffirmed
Jefferies Analyst forecast on CH:4QK
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF2.83
Buy
―
Assigned
04/01/26
Codexis (CDXS) Gets a Buy from Jefferies
Benchmark Co. Analyst forecast on CH:4QK
Robert Wasserman
Benchmark Co.
Benchmark Co.
―
Hold
―
Reiterated
11/14/25
Analysts Offer Insights on Healthcare Companies: Immunic (NASDAQ: IMUX), Codexis (NASDAQ: CDXS) and Oric Pharmaceuticals (NASDAQ: ORIC)
Stifel Nicolaus Analyst forecast on CH:4QK
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
CHF4.04
Buy
―
Reiterated
11/10/25
Stifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CH:4QK
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/25/26
Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)
Cantor Fitzgerald Analyst forecast on CH:4QK
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
CHF8.9
Buy
―
Reiterated
06/16/26
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (NASDAQ: EWTX), Gilead Sciences (NASDAQ: GILD) and Codexis (NASDAQ: CDXS)
Piper Sandler Analyst forecast on CH:4QK
Allison Bratzel
Piper Sandler
Piper Sandler
CHF7.28
Buy
―
Reiterated
05/08/26
Codexis (CDXS) Gets a Buy from Piper Sandler
TD Cowen Analyst forecast on CH:4QK
Brendan Smith
TD Cowen
TD Cowen
CHF1.62
Hold
―
Reiterated
05/07/26
Codexis: Neutral Stance Maintained as Execution Risks Offset Solid Q1; $2 Price Target Reaffirmed
Jefferies Analyst forecast on CH:4QK
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF2.83
Buy
―
Assigned
04/01/26
Codexis (CDXS) Gets a Buy from Jefferies
Benchmark Co. Analyst forecast on CH:4QK
Robert Wasserman
Benchmark Co.
Benchmark Co.
―
Hold
―
Reiterated
11/14/25
Analysts Offer Insights on Healthcare Companies: Immunic (NASDAQ: IMUX), Codexis (NASDAQ: CDXS) and Oric Pharmaceuticals (NASDAQ: ORIC)
Stifel Nicolaus Analyst forecast on CH:4QK
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
CHF4.04
Buy
―
Reiterated
11/10/25
Stifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Codexis

3 Months
Matt HewittCraig-Hallum
Success Rate
13/27 ratings generated profit
48%
Average Return
+4.02%
Copying Matt Hewitt's trades and holding each position for 3 Months would result in 48.15% of your transactions generating a profit, with an average return of +4.02% per trade.
1 Year
Matt HewittCraig-Hallum
Success Rate
12/27 ratings generated profit
44%
Average Return
+7.47%
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +7.47% per trade.
2 Years
Matt HewittCraig-Hallum
Success Rate
6/27 ratings generated profit
22%
Average Return
-10.47%
Copying Matt Hewitt's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -10.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4QK Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
3
6
6
4
Buy
4
4
4
2
1
Hold
1
1
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
8
12
9
6
In the current month, 4QK has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 4QK average Analyst price target in the past 3 months is 5.93.
Each month's total comprises the sum of three months' worth of ratings.

4QK Financial Forecast

4QK Earnings Forecast

Next quarter’s earnings estimate for 4QK is -CHF0.11 with a range of -CHF0.14 to -CHF0.07. The previous quarter’s EPS was -CHF0.08. 4QK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 4QK has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4QK is -CHF0.11 with a range of -CHF0.14 to -CHF0.07. The previous quarter’s EPS was -CHF0.08. 4QK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 4QK has Performed in-line its overall industry.

4QK Sales Forecast

Next quarter’s sales forecast for 4QK is CHF11.12M with a range of CHF8.59M to CHF12.87M. The previous quarter’s sales results were CHF12.26M. 4QK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 4QK has Performed in-line its overall industry.
Next quarter’s sales forecast for 4QK is CHF11.12M with a range of CHF8.59M to CHF12.87M. The previous quarter’s sales results were CHF12.26M. 4QK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 4QK has Performed in-line its overall industry.

4QK Stock Forecast FAQ

What is CH:4QK’s average 12-month price target, according to analysts?
Based on analyst ratings, Codexis’s 12-month average price target is 5.93.
    What is CH:4QK’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:4QK, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Codexis a Buy, Sell or Hold?
        Codexis has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Codexis’s share price target?
          The average share price target for Codexis is 5.93. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF8.90 ,and the lowest forecast is CHF1.62. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Codexis?
            Codexis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
              How can I buy shares of Codexis?
              To buy shares of CH:4QK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.